Takeda (NYSE: TAK) executive reports 225,239 ADS including RSUs

Rhea-AI Filing Summary

Takeda Pharmaceutical executive Giles Richard Platford, President of PDT, filed an initial ownership report showing beneficial ownership of 225,239 American Depositary Shares. This total includes 94,620 restricted stock units, each representing a contingent right to receive one American Depositary Share.

The restricted stock units vest over three dates: 44,638 shares on July 1, 2026, 32,396 shares on July 1, 2027, and 17,586 shares on July 1, 2028. These awards reflect equity-based compensation that will convert into shares only as they vest over time.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Platford Giles Richard

Role President, PDT

Type	Security	Shares	Price	Value
holding	American Depositary Shares	--	--	--

Holdings After Transaction: American Depositary Shares — 225,239 shares (Direct)

Footnotes (1)

1. F1. Includes 94,620 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest on the following schedule: July 1, 2026 (44,638 shares), July 1, 2027 (32,396 shares) and July 1, 2028 (17,586 shares).

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Accepted by SEC EDGAR 03/18/2026 - 06:11 AM Learn about SEC filing dates

FAQ

Who is the insider reporting holdings in Takeda (TAK) on this Form 3?

The insider is Giles Richard Platford, who serves as President, PDT at Takeda Pharmaceutical. The Form 3 reports his initial beneficial ownership position in the company’s American Depositary Shares and related equity awards.

How many Takeda (TAK) American Depositary Shares does Giles Richard Platford report?

Giles Richard Platford reports beneficial ownership of 225,239 American Depositary Shares. This figure reflects his direct holdings, including restricted stock units that will settle into shares as they vest over the specified future dates.

What restricted stock units are included in Giles Richard Platford’s Takeda (TAK) holdings?

His reported position includes 94,620 restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share of Takeda, subject to future vesting conditions and the specified vesting schedule.

What is the vesting schedule for Giles Richard Platford’s Takeda (TAK) RSUs?

The RSUs vest in three tranches: 44,638 shares on July 1, 2026, 32,396 shares on July 1, 2027, and 17,586 shares on July 1, 2028. Each vested RSU converts into one American Depositary Share.

Does this Takeda (TAK) Form 3 show any insider buying or selling activity?

This Form 3 reports initial beneficial ownership and does not show explicit insider purchases or sales. It primarily discloses Giles Richard Platford’s existing American Depositary Share holdings and unvested restricted stock units with their future vesting schedule.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Platford Giles Richard

(Last) (First) (Middle)

650 E. KENDALL STREET

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, PDT

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
American Depositary Shares	225,239(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 94,620 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest on the following schedule: July 1, 2026 (44,638 shares), July 1, 2027 (32,396 shares) and July 1, 2028 (17,586 shares).

Remarks:

Exhibit 24 Power of Attorney

	/s/ Max Heuer, by power of attorney, for Giles Platford	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)